For: | Abbas Z, Abbas M. Management of hepatitis delta: Need for novel therapeutic options. World J Gastroenterol 2015; 21(32): 9461-9465 [PMID: 26327754 DOI: 10.3748/wjg.v21.i32.9461] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i32/9461.htm |
Number | Citing Articles |
1 |
Nathalie Mentha, Sophie Clément, Francesco Negro, Dulce Alfaiate. A review on hepatitis D: From virology to new therapies. Journal of Advanced Research 2019; 17: 3 doi: 10.1016/j.jare.2019.03.009
|
2 |
I. P. Balmasova, R. I. Sepiashvili, T. A. Slavyanskaya, E. S. Malova, Ya. R. Sepiashvili. COINFECTION BY HEPATITIS B AND HEPATITIS DELTA VIRUSES: MOLECULAR BIOLOGY OF PATHOGENS AND PROSPECTS OF PHARMACOTHERAPY. Journal of microbiology, epidemiology and immunobiology 2018; 95(2): 95 doi: 10.36233/0372-9311-2018-2-95-102
|
3 |
Hannah Nam, Kathy M. Nilles, Josh Levitsky, Michael G. Ison. Donor-derived Viral Infections in Liver Transplantation. Transplantation 2018; 102(11): 1824 doi: 10.1097/TP.0000000000002326
|
4 |
Grazia A Niro, Arianna Ferro, Francesca Cicerchia, Isabella Brascugli, Marilena Durazzo. Hepatitis delta virus: From infection to new therapeutic strategies. World Journal of Gastroenterology 2021; 27(24): 3530-3542 doi: 10.3748/wjg.v27.i24.3530
|
5 |
Nazish Butt, Muhammad T Usmani, Riaz Hussain, Saba Mughal, Fakhar A Qazi Arisar. Efficacy of Pegylated Interferon-alpha-2a in Chronic Hepatitis Delta: Experience from a Tertiary Care Hospital in Karachi. Euroasian journal of hepato-gastroenterology 2024; 14(1): 51 doi: 10.5005/jp-journals-10018-1431
|
6 |
David Tabernero, Maria Francesca Cortese, Maria Buti, Francisco Rodriguez-Frias. HDV evolution—will viral resistance be an issue in HDV infection?. Current Opinion in Virology 2018; 32: 100 doi: 10.1016/j.coviro.2018.10.003
|
7 |
Vanessa Zhu, Jürgen Burhenne, Johanna Weiss, Mathias Haag, Ute Hofmann, Matthias Schwab, Stephan Urban, Gerd Mikus, David Czock, Walter E. Haefeli, Antje Blank. Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1128547
|
8 |
Zakey Yusuf Buuh, Zhigang Lyu, Rongsheng E. Wang. Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins. Journal of Medicinal Chemistry 2018; 61(8): 3239 doi: 10.1021/acs.jmedchem.6b01817
|
9 |
Angela Quirino, Nadia Marascio, Francesco Branda, Alessandra Ciccozzi, Chiara Romano, Chiara Locci, Ilenia Azzena, Noemi Pascale, Grazia Pavia, Giovanni Matera, Marco Casu, Daria Sanna, Marta Giovanetti, Giancarlo Ceccarelli, Pierfrancesco Alaimo di Loro, Massimo Ciccozzi, Fabio Scarpa, Antonello Maruotti. Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies. Pathogens 2024; 13(9): 766 doi: 10.3390/pathogens13090766
|
10 |
Beatriz Pacin-Ruiz, María Francesca Cortese, David Tabernero, Sara Sopena, Josep Gregori, Selene García-García, Rosario Casillas, Adrián Najarro, Unai Aldama, Adriana Palom, Ariadna Rando-Segura, Anna Galán, Marta Vila, Mar Riveiro-Barciela, Josep Quer, Gloria González-Aseguinolaza, María Buti, Francisco Rodríguez-Frías. Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability. Viruses 2022; 14(2): 215 doi: 10.3390/v14020215
|